Epstein Secrets

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

xanda Kotey and El Shafee Elsheikh to US authorities." The New York Times <https://www.nytimes.com/2020/09/22/us/politics/isis-beatles.html> (9/22, Savage, 18.61 M) reports a DOJ spokesman, Marc Raimondi, responded to the British announcement, "We are pleased with the U.K. High Court's decision and we

-covid- vaccine-trial-in-days?smd=premium> (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 EFTA00137117 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

M), the Los Angeles Times <https://www.latimes.corn/politics/story/2020- 11-10/supreme-court-hears-latest-gop-bid-to-strike-down- obamacare> (11/10, Savage, Levey, 4.64M), the New York Daily News <https://www.nydailynews.com/news/politics/ny-obamacare-supreme-court-arguments-20201110- gjzazkutinecdorofr

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

r the states and individuals had the right to bring the lawsuit." Bloomberg (11/10, Stohr, Wheeler, Robinson, 4.73M), the Los Angeles Times (11/10, Savage, Levey, 4.64M), the New York Daily News (11/10, Sommerfeldt, 2.52M), Axios (11/10, Baker, 521K), The Hill (11/10, Kruzel, 2.98M), and the Fox News (

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

firmed the transfer of the evidence regarding alleged militants Alexanda Kotey and El Shafee Elsheikh to US authorities." The New York Times (9/22, Savage, 18.61M) reports a DOJ spokesman, Marc Raimondi, responded to the British announcement, "We are pleased with the U.K. High Court's decision and we

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

firmed the transfer of the evidence regarding alleged militants Alexanda Kotey and El Shafee Elsheikh to US authorities." The New York Times (9/22, Savage, 18.61M) reports a DOJ spokesman, Marc Raimondi, responded to the British announcement, "We are pleased with the U.K. High Court's decision and we

e Trial Ready To Analyze Shot's Effectiveness. Bloomberg (11/11, Langreth, 4.73M) reports that the "same US explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna's trial." Moderna "said Wednesday its study has accumulated more

r the states and individuals had the right to bring the lawsuit." Bloomberg (11/10, Stohr, Wheeler, Robinson, 4.73M), the Los Angeles Times (11/10, Savage, Levey, 4.64M), the New York Daily News (11/10, Sommerfeldt, 2.52M), Axios (11/10, Baker, 521K), The Hill (11/10, Kruzel, 2.98M), and the Fox News (